Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection

Journal of Infectious Diseases

Volumn 194, Issue 6, 2006, Pages 819-827

  Wickham, Mark E ^a   Lupp, Claudia ^a,e   Mascarenhas, Mariola ^b   Vázquez, Alejandra ^d   Coombes, Brian K ^a,c   Brown, Nat F ^a   Coburn, Bryan A ^a   Deng, Wanyin ^a   Puente, José L ^a,d   Karmali, Mohamed A ^b   Finlay, B Brett ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HEALTH CANADA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^e Nature Publishing Group Palgrave Macmillan   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIC; HEMOLYTIC UREMIC SYNDROME; HUMAN; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PUBLIC HEALTH; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ANIMALS; CITROBACTER RODENTIUM; COLON; DISEASE MODELS, ANIMAL; DISEASE OUTBREAKS; DNA PRIMERS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOMIC ISLANDS; HEMOLYTIC-UREMIC SYNDROME; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PREVALENCE; SHIGA TOXINS; SURVIVAL ANALYSIS; TIME FACTORS; VIRULENCE; VIRULENCE FACTORS;

EID: 33748431496     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/506620     Document Type: Article

References (44)

1. Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983; 1:619-20.
2. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977; 18:775-9.
3. Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308:681-5.
4. O'Brien AO, Lively TA, Chen ME, Rothman SW, Formal SB. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet 1983; 1:702.
5. Elliott EJ, Robins-Browne RM, O'Loughlin EV, et al. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 2001; 85:125-31.
6. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002; 186:493-500.
7. Paton AW, Ratcliff RM, Doyle RM, et al. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J Clin Microbiol 1996; 34:1622-7.
8. Caprioli A, Tozzi AE, Rizzoni G, Karch H. Non-O157 Shiga toxin-producing Escherichia coli infections in Europe. Emerg Infect Dis 1997; 3:578-9.
9. Schmidt H, Geitz C, Tarr PI, Frosch M, Karch H. Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J Infect Dis 1999; 179:115-23.
10. Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 1990; 87:7839-43.
11. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 1997; 91:511-20.
12. Garmendia J, Phillips AD, Carlier MF, et al. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol 2004; 6:1167-83.
13. Campellone KG, Robbins D, Leong JM. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. Dev Cell 2004; 7:217-28.
14. Grys TE, Siegel MB, Lathem WW, Welch RA. The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells. Infect Immun 2005; 73:1295-303.
15. Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC. A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp Med 2004; 200:35-46.
16. Marches O, Ledger TN, Boury M, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol 2003; 50:1553-67.
17. Gruenheid S, Sekirov I, Thomas NA, et al. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 2004; 51:1233-49.
18. Mundy R, Petrovska L, Smollett K, et al. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun 2004; 72:2288-302.
19. Deng W, Puente JL, Gruenheid S, et al. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci USA 2004; 101:3597-602.
20. Mundy R, Jenkins C, Yu J, Smith H, Frankel G. Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates. J Med Microbiol 2004; 53:1145-9.
21. Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, Griffin PM. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997; 126:505-13.
22. Cohen MB. Shiga toxin-producing E coli: two tests are better than one. J Pediatr 2002; 141:155-6.
23. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365:1073-86.
24. Perna NT, Plunkett G III, Burland V, et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 2001; 409:529-33.
25. Karmali MA, Mascarenhas M, Shen S, et al. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 2003; 41:4930-40.
26. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97:6640-5.
27. Yokoyama K, Makino K, Kubota Y, et al. Complete nucleotide sequence of the prophage VT1-Sakai carrying the Shiga toxin 1 genes of the enterohemorrhagic Escherichia coli O157:H7 strain derived from the Sakai outbreak. Gene 2000; 258:127-39.
28. Vallance BA, Deng W, Jacobson K, Finlay BB. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 2003; 71:3443-53.
29. Reed MJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493-7.
30. Shen S, Mascarenhas M, Rahn K, Kaper JB, Karmali MA. Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113;H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48. Infect Immun 2004; 72:1496-503.
31. Klapproth JM, Sasaki M, Sherman M, et al. Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo. Infect Immun 2005; 73:1441-51.
32. Beuzon CR, Holden DW. Use of mixed infections with Salmonella strains to study virulence genes and their interactions in vivo. Microbes Infect 2001; 3:1345-52.
33. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11:142-201.
34. Klein EJ, Stapp JR, Clausen CR, et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 2002; 141:172-7.
35. Klein EJ, Stapp JR, Neill MA, Besser JM, Osterholm MT, Tarr PI. Shiga toxin antigen detection should not replace sorbitol MacConkey agar screening of stool specimens. J Clin Microbiol 2004; 42:4416; author reply 4416-7.
36. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2:123-40.
37. Bell BP, Goldoft M, Griffin PM, et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: the Washington experience. JAMA 1994; 272:1349-53.
38. Rowe PC, Orrbine E, Ogborn M, et al. Epidemic Escherichia coli O157: H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian Inuit community: intestinal illness in family members as a risk factor. J Pediatr 1994; 124:21-6.
39. Wick LM, Qi W, Lacher DW, Whittam TS. Evolution of genomic content in the stepwise emergence of Escherichia coli O157:H7. J Bacteriol 2005; 187:1783-91.
40. Ohnishi M, Terajima J, Kurokawa K, et al. Genomic diversity of enterohemorrhagic Escherichia coli O157 revealed by whole genome PCR scanning. Proc Natl Acad Sci USA 2002; 99:17043-8.
41. Dean-Nystrom EA, Melton-Celsa AR, Pohlenz JF, Moon HW, O'Brien AD. Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs. Infect Immun 2003; 71:6526-33.
42. Dean-Nystrom EA, Bosworth BT, Cray WC Jr, Moon HW. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun 1997; 65:1842-8.
43. McKee ML, Melton-Celsa AR, Moxley RA, Francis DH, O'Brien AD. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun 1995; 63:3739-44.
44. Kim J, Nietfeldt J, Benson AK. Octamer-based genome scanning distinguishes a unique subpopulation of Escherichia coli O157:H7 strains in cattle. Proc Natl Acad Sci USA 1999; 96:13288-93.